Enzyme provides an automated software system that helps health startups manage FDA compliance and documentation by integrating with tools like Jira, Trello and GitHub. The platform reduces duplicated paperwork and aims to let teams comply without deep regulatory expertise. Co-founders Jared Seehafer and regulations expert Jake Graham launched Enzyme out of beta last summer. So far the company is working with about 10 customers and has raised $1.85 million from investors. Enzyme plans aggressive 2018 growth focused on early funded digital health companies and is pursuing partnerships with accelerators and VC firms to expand distribution.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2018